The primary impact of using the covalidation model is the expedited analytical method qualification of both the transferring and receiving laboratories.
Yueer Shi
Advertisement
Yueer Shi is group leader, Bristol Myers Squibb, USA, [email protected]
Articles by Yueer Shi
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Activity Round Up – July 2026
2
Midyear 2026 Check-In: Agentic AI Cuts Deviation Investigations by 50%
3
Can Governance-by-Design Make AI Compliant in Pharma? (Part II)
4
From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026
5